Parth Hemant Parikh – - - Kesar Pharma Pvt Ltd of Kesar Pharma

View Detailed Executive Profile →

Professional Overview

  • Parth Hemant Parikh holds the Director Identification Number (DIN) 08542493 and is currently the director of multiple companies, including Vipronova Lifescience Private Limited and Kesar Pharma Private Limited.
  • In the role of director at Kesar Pharma Private Limited, Parth Parikh has been associated with the company since February 22, 2021, contributing to its operations in the pharmaceutical industry.
  • Parth Parikh's leadership extends to Vipronova Lifescience Private Limited, where they have served as director since April 8, 2021, fostering advancements in life sciences.
  • In addition to these roles, Parth Parikh is affiliated with several other companies, showcasing their active involvement in diverse business operations.
  • Parth Parikh emphasizes continuous learning and personal growth, indicating a commitment to professional development and adaptability in a dynamic business environment.
  • Described as a passionate team player, Parth Parikh thrives in collaborative settings while also possessing the capability to work independently on solutions.
  • The associated companies under Parth Parikh's direction, such as Kesar Finechem Private Limited and Meghdhanush Drones, reflect a diversified approach to business in various industrial sectors.
  • Through these engagements, Parth Parikh contributes to the pharmaceutical and life sciences sectors, reinforcing the importance of innovation and leadership in these fields.
Professional Experience
CompanyDesignationPeriod
University of Massachusetts AmherstDigital Media Lab student assistantSep 2014 – Dec 2014
IIFL Wealth Management LtdInternJun 2014 – Aug 2014
PRAVIN RATILAL SHARE AND STOCK BROKERS LIMITEDSummer Finance InternJun 2013 – Jul 2013
ALTS CapitalAccelerator Participant Cohort 6Apr 2020 – Jul 2020
Kesar Pharma Pvt Ltd-Apr 2019 – Present
XO Software LimitedPrincipalApr 2018 – Present
Meghdhanush Drones & Agro Technologies Private LimitedDirector15 Apr 2024 – Present
Vital Intelligence Technology Private LimitedAdditional Director09 Dec 2024 – Present
Vipronova Lifescience Private LimitedDirector08 Apr 2021 – Present
Kesar Pharma LimitedDirector06 Sep 2019 – Present
Kesar Finechem Private LimitedDirector05 Sep 2022 – Present
Winfra Green Projects Private LimitedDirector05 Sep 2019 – Present
Current Appointments
CIN/LLPCompanyDesignationDate
U24230GJ2021PTC127102Kesar Finechem Private LimitedDirector05 Sep 2022
U24232GJ2021PTC121847Vipronova Lifescience Private LimitedDirector08 Apr 2021
U24239GJ2011PLC067520Kesar Pharma LimitedDirector06 Sep 2019
U26515GJ2024PTC150623Meghdhanush Drones & Agro Technologies Private LimitedDirector15 Apr 2024
U70100GJ2008PTC055654Winfra Green Projects Private LimitedDirector05 Sep 2019
U72200GJ2012PTC070032Vital Intelligence Technology Private LimitedAdditional Director09 Dec 2024

Estimated Net Worth

Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)

Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.

Executive Contact

Official Email: Via Kesar Pharma corporate communication desk.

Personal Contact: Not publicly disclosed.

Frequently Asked Questions

What is Parth Hemant Parikh's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).

How can I contact them?
Through Kesar Pharma's official communication channels.

Is this an official profile?
No — independently created using public data.

Disclaimer

This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.

Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.

Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.

Affluense AI – Smarter Insights. Stronger Relationships with Affluents.

Last Updated: December 2025 · Published by Affluense AI (affluense.ai)

View Detailed Executive Profile →